You are here :
Published on: May 2017 | From USD $990 | Published By: DPI RESEARCH | Number Of Pages: 110
United States Blood Glucose Meter Market is likely to reach USD 650 Million by the year end of 2022.
Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes mellitus, improved glucose control and flexible, userfriendly design, government efforts for better management of diabetes mellitus and technological advancement in blood glucose meter devices.
The research report titled United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 2022 examines the market, competitive landscape and trends of the United States Blood Glucose Meter Market. The study provides an indepth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. Moreover, it also provides an essential insight on insulin users.
The report provides a decisive view on the Blood Glucose Meter Users and Market. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States Blood Glucose Meter Market. Key trends in terms of collaboration, partnership, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Blood Glucose Meter Market. The report concludes with the profiles of major players in the United States Blood Glucose Meter Market. The key market players are evaluated on various parameters such as company overview, marketed products and latest development and trends of the Blood Glucose Meter Market.
Key Topics Covered in the Report
United States Diabetes Population (2011 2022)
Insulin Users (2011 2022)
United States Blood Glucose Meter Users and Market Analysis (2011 2022)
United States Blood Glucose Meter Market: Reimbursement & Regulation System
United States Blood Glucose Meter Market Major Deal Types
Key Companies Analysis
Key Drivers and Inhibitors of the United States Blood Glucose Meter Market
Key Companies Covered in the Report are as follows:
Roche
LifeScan Inc
Abbott Diabetes Care
Arkray
Ascensia Diabetes Care
Fora Care
Entra Health
Fifty50 Medical
Infopia
Genesis Health Technologies
iHealth Labs
Oak Tree Health
Livongo Health
Nova Diabetes Care
Sanofi Diabetes
Telcare
Walgreens
U.S. Diagnostics
Prodigy Diabetes Care
Omnis Health
1. Executive Summary
2. United States Diabetes Population (2011 Β 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
2.1.4 Insulin Users
3. United States Blood Glucose Meter Market Analysis (2011Β 2022)
3.1 Blood Glucose Meter Users
3.2 Blood Glucose Meter Market
4. Key Drivers and Inhibitors of the United States Blood Glucose Meter Market
4.1 Market Drivers
4.2 Inhibitors
5. United States Blood Glucose Meter Market: Reimbursement & Regulation System
5.1 Reimbursement System
5.2 Regulation System
6. United States Blood Glucose Meter Market Β Major Deal Types
6.1 Blood Glucose Meter Market Β Collaboration Deals
6.2 Blood Glucose Meter Market Β Licensing Agreement
6.3 Blood Glucose Meter Market Β Partnership Deals
6.4 Blood Glucose Meter Market Β Distribution Agreement
7. Key Companies Analysis
7.1 Roche
7.1.1 Business Overview
7.1.2 Blood Glucose Meter Β Marketed Products
7.1.3 Blood Glucose Meter Β Latest Development & Trends
7.2 LifeScan Inc
7.2.1 Business Overview
7.2.2 Blood Glucose Meter Β Marketed Products
7.2.3 Blood Glucose Meter Β Latest Development & Trends
7.3 Abbott Diabetes Care
7.3.1 Business Overview
7.3.2 Blood Glucose Meter Β Marketed Products
7.3.3 Blood Glucose Meter Β Latest Development & Trends
7.4 Arkray
7.4.1 Business Overview
7.4.2 Blood Glucose Meter Β Marketed Products
7.4.3 Blood Glucose Meter Β Latest Development & Trends
7.5 Ascensia Diabetes Care
7.5.1 Business Overview
7.5.2 Blood Glucose Meter Β Marketed Products
7.5.3 Blood Glucose Meter Β Latest Development & Trends
7.6 Fora Care
7.6.1 Business Overview
7.6.2 Blood Glucose Meter Β Marketed Products
7.6.3 Blood Glucose Meter Β Latest Development & Trends
7.7 Entra Health (Acquired by CRF Health)
7.7.1 Business Overview
7.7.2 Blood Glucose Meter Β Marketed Products
7.7.3 Blood Glucose Meter Β Latest Development & Trends
7.8 Fifty50 Medical
7.8.1 Business Oveview
7.8.2 Blood Glucose Meter Β Marketed Products
7.9 Infopia
7.9.1 Business Ovieview
7.9.2 Blood Glucose Meter Β Marketed Products
7.10 Genesis Health Technologies
7.10.1 Business Overview
7.10.2 Blood Glucose Meter Β Marketed Products
7.11 iHealth Labs
7.11.1 Business Overview
7.11.2 Blood Glucose Meter Β Marketed Products
7.12 Oak Tree Health
7.12.1 Business Overview
7.12.2 Blood Glucose Meter Β Marketed Products
7.13 Livongo Health
7.13.1 Business Overview
7.13.2 Blood Glucose Meter Β Marketed Products
7.13.3 Blood Glucose Meter - Latest Development & Trends
7.14 Nova Diabetes Care
7.14.1 Business Overview
7.14.2 Blood Glucose Meter Β Marketed Products
7.15 Sanofi Diabetes
7.15.1 Business Overview
7.15.2 Blood Glucose Meter Β Marketed Products
7.16 Telcare
7.16.1 Business Overview
7.16.2 Blood Glucose Meter Β Marketed Products
7.17 Walgreens
7.17.1 Business overview
7.17.2 Blood Glucose Meter Β Marketed Products
7.18 U.S. Diagnostics
7.18.1 Business Overview
7.18.2 Blood Glucose Meter Β Marketed Products
7.18.3 Blood Glucose Meter Β Latest Development & Trends
7.19 Prodigy Diabetes Care
7.19.1 Business Overview
7.19.2 Blood Glucose Meter Β Marketed Products
7.19.3 Blood Glucose Meter Β Latest Development & Trends
7.20 Omnis Health
7.20.1 Business Overview
7.20.2 Blood Glucose Meter Β Marketed Products
7.20.3 Blood Glucose Meter Β Latest Development & Trends
List of Tables
Table 4 1: Worldwide Β Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 6 1: Collaboration Deals in Blood Glucose Meter Market, 2014 Β 2015
Table 6 2: Licensing Agreement in Blood Glucose Meter Market , 2012
Table 6 3: Partnership Deals in Blood Glucose Meter Market, 2009 Β 2017
Table 6 4: Distribution Agreement in Blood Glucose Meter Market, 2011 Β 2016
Table 7 1: Roche: Blood Glucose Meter Marketed Products
Table 7 2: LifeScan: Blood Glucose Meter Marketed Products
Table 7 3: Abbott Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 4: Arkray: Blood Glucose Meter Marketed Products
Table 7 5: Ascensia Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 6: Fora Care: Blood Glucose Meter Marketed Products
Table 7 7: Entra Health: Blood Glucose Meter Marketed Products
Table 7 8: Fifty50 Medical: Blood Glucose Meter Marketed Products
Table 7 9: Infopia: Blood Glucose Meter Marketed Products
Table 7 10: Genesis Health Technologies: Blood Glucose Meter Marketed Products
Table 7 11: iHealth Labs: Blood Glucose Meter Marketed Products
Table 7 12: Oak Tree Health: Blood Glucose Meter Marketed Products
Table 7 13: Livongo Health: Blood Glucose Meter Marketed Products
Table 7 14: Nova Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 15: Sanofi: Blood Glucose Meter Marketed Products
Table 7 16: Telcare: Blood Glucose Meter Marketed Products
Table 7 17: Walgreens: Blood Glucose Meter Marketed Products
Table 7 18: U.S. Diagnostics: Blood Glucose Meter Marketed Products
Table 7 19: Prodigy Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 20: Omnis Health: Blood Glucose Meter Marketed Products
List of Figures
Figure 2 1: United States Β Overall Diabetes Population (Thousand), 2011 Β 2016
Figure 2 2: United States Β Forecast for Overall Diabetes Population (Thousand), 2017 Β 2022
Figure 2 3: United States Β Type 1 Diabetes Population (Thousand), 2011 Β 2016
Figure 2 4: United States Β Forecast for Type 1 Diabetes Population (Thousand), 2017 Β 2022
Figure 2 5: United States Β Type 2 Diabetes Population (Thousand), 2011 Β 2016
Figure 2 6: United States Β Forecast for Type 2 Diabetes Population (Thousand), 2017 Β 2022
Figure 2 7: United States Β Newly Diagnosed Type 1 Diabetes Population (Number), 2011 Β 2016
Figure 2 8: United States Β Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 Β 2022
Figure 2 9: United States Β Insulin Users(Thousand),2011 Β 2016
Figure 2 10: United States Β Forecast for Insulin Users(Thousand),2017 Β 2022
Figure 3 1: United States Β Blood Glucose Meter Users (Thousand), 2011 Β 2016
Figure 3 2: United States Β Forecast for Blood Glucose Meter Users (Thousand), 2017 Β 2022
Figure 3 3: United States Β Blood Glucose Meter Market (Million US$), 2011 Β 2016
Figure 3 4: United States Β Forecast for Blood Glucose Meter Market (Million US$), 2017 Β 2022
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.